Thuc c k n dng h tr c hiu qu trong nhiu bnh l khc nhau
The development of further dual GLP-1/GIP receptor agonists seems to be a promising next step in managing various cardiovascular disease
Calabrese, V., Colombrita, C., Sultana, R., Scapagnini, G., Calvani, M., Butterfield, D
108 This has lead to the proposal that PP may behave as a circulating satiety signal
Recent research has revealed that GLP-1 receptor agonists have potent anti-inflammatory properties that extend well beyond their metabolic effects, targeting different pathways in different tissues and demonstrating a broad spectrum of actions